Zebra Medical Vision develops AI-based medical image analysis that helps radiologists detect chronic and acute conditions.
Zebra Medical Vision Ltd. (Zebra-Med) analyzes medical imaging data to identify early signs of common chronic diseases, giving radiologists and healthcare institutions tools for diagnosis and preventative treatment. Founded in 2014 by co-founders Eyal Toledano and Eyal Gura and based in Kibutz Shfayim, Israel, the company had seven US FDA-approved and ten CE-marked AI solutions as of 2021. Nanox acquired Zebra Medical Vision in August 2021 for USD 200 million.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in